TSBX – turnstone biologics corp. (US:NASDAQ)
Stock Stats
News
Turnstone Biologics Corp. (NASDAQ: TSBX) had its price target lowered by analysts at Piper Sandler from $20.00 to $3.75. They now have an "overweight" rating on the stock.
Turnstone Biologics Corp. (NASDAQ: TSBX) had its price target lowered by analysts at Bank of America Co. from $12.00 to $10.00. They now have a "buy" rating on the stock.
Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal Cancer [Yahoo! Finance]
Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights
Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal Cancer
Form 10-Q Turnstone Biologics Corp For: Jun 30
Form 8-K Turnstone Biologics Corp For: Aug 14
Form 4 Turnstone Biologics Corp For: Jun 03 Filed by: Rajangam Kanya
Form 4 Turnstone Biologics Corp For: Jun 03 Filed by: Gould Robert J
Form 4 Turnstone Biologics Corp For: Jun 03 Filed by: Waddill William D.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.